CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Diana Do, MD, discusses the PHOTON extension study, which examined the effect of Eylea HD in patients with diabetic macular edema.
Do said patients treated with Eylea HD (aflibercept 8 mg, Regeneron) who achieved vision and anatomic gains in the first 2 years of the PHOTON trial were able to maintain their improvements in the extension study.
“The PHOTON data gives physicians more information about 8 mg of aflibercept for diabetic macular edema, showing that (Read more...)